Dentists in Cambridge, NE Accepting Medicare
2 Dentists found. Showing 1 - 2
 Dr. Dean Darlington Cope, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 40890 W. Highway 6 & 34, Cambridge, NE 69022 Phone: 308-697-3736 Fax: 308-697-3705 |
 Dr. Lindsey White, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 40890 W. Hwy 6 & 34, Cambridge, NE 69022 Phone: 308-697-3736 |
News Archive
CPRIT awards $48.2 million in new grants to investigators at UT Southwestern Medical Center
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $48.2 million in new grants to investigators at UT Southwestern Medical Center to support cancer-related projects and to recruit pre-eminent cancer researchers.
Calibra Medical's Finesse insulin patch-pen receives FDA clearance for use with Novo Nordisk's Novolog
Calibra Medical announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Finesse™ insulin patch-pen for up to three-day use with Novo Nordisk's Novolog® rapid acting insulin. Combining the mealtime therapy-adherence benefits of insulin pumps with the simplicity and affordability of syringes and pens, Calibra's novel bolus-only patch-pen is a small, adhesively attached, flat device that can be operated discretely through clothing to deliver mealtime, snack time, and correction bolus insulin in seconds.
Discovery that sheds new light upon the growth and development of human natural killer (NK) cells
Scientists here have made a major discovery that sheds new light upon the growth and development of human natural killer (NK) cells, powerful but somewhat mysterious components of the body's immune system that are the first line of defense against cancer and infectious diseases.
New inhibitor of SARS-CoV-2 RNA translation
As the search for effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inhibitors continues, a recent study by Yale University School of Medicine researchers published on the preprint server bioRxiv in October 2020 reports the inhibitory effect of the drug merofloxacin on frameshifting during SARS-CoV-2 replication.
Oral formulation of insulin shows promise in management of blood glucose in diabetic rats
An intestinal patch device containing insulin that can be swallowed in the form of a capsule, in development by researchers at University of California Santa Barbara, has demonstrated efficacy of blood glucose management in diabetic rats. This work is being presented Oct. 27 at the 2015 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in Orlando, Fla. Oct. 25-29.
› Verified 8 days ago